Systematic Evaluation of the Quality of Randomized Controlled Trials in Diabetes
Open Access
- 1 August 2006
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (8) , 1833-1838
Abstract
OBJECTIVE—We sought to systematically ascertain the quality of randomized controlled trials (RCTs) in diabetes. RESEARCH DESIGN AND METHODS—We identified the 10 most recently published trials as of 31 October 2003 in each of six general medical, five diabetes, and five metabolism and nutrition journals and further enriched our sample with 10 additional RCTs from each of five journals that published the most eligible RCTs in a year. We explored the association between trial characteristics and reporting quality using univariate analyses and a preplanned multivariate regression model. RESULTS—After excluding redundant reports of included trials and one trial that measured outcomes on the health system and not on patients, we included 199 RCTs: 119 assessed physiological and other laboratory outcomes, 42 assessed patient-important outcomes (e.g., morbidity and mortality, quality of life), and 38 assessed surrogate outcomes (e.g., disease progression or regression, HbA1c, cholesterol). Fifty-three percent were of low methodological quality, as were one-third (36–40%) of trials reporting patient-important or surrogate outcomes and two-thirds (64%) of laboratory investigations. Independent predictors of low quality were nonprofit funding source (odds ratio 3.1 [95% CI 1.5–6.2]), measure of physiological and laboratory outcomes (2.3 [1.2–4.4]), and cross-over design (2.3 [1.1–4.8]), all characteristics of laboratory clinical investigations. CONCLUSIONS—There is ample room for improving the quality of diabetes trials. To enhance the practice of evidence-based diabetes care, trialists need to pay closer attention to the rigorous implementation and reporting of important methodological safeguards against bias in randomized trials.Keywords
This publication has 23 references indexed in Scilit:
- The quality of randomized trial reporting in leading medical journals since the revised CONSORT statementContemporary Clinical Trials, 2005
- An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistentlyJournal of Clinical Epidemiology, 2005
- Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort studyBMJ, 2005
- An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methodsJournal of Clinical Epidemiology, 2004
- Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals)Canadian Medical Association Journal, 2004
- Evidence-Based EndocrinologyTreatments in Endocrinology, 2004
- Allocation Concealment in Clinical TrialsJAMA, 2002
- What is evidence-based medicine?Endocrinology and Metabolism Clinics of North America, 2002
- Value of Flow Diagrams in Reports of Randomized Controlled TrialsJAMA, 2001
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsJAMA, 2001